Abstract
Glaucoma is a common eye disease associated with elevated intraocular pressure (IOP). Lowering IOP is the only acceptable therapy for glaucoma and slows progression of the disease. Filtration surgery, which introduces a guarded ostomy through the sclera into the anterior chamber of the eye to allow the escape of aqueous humor, is the most reliable method for effective IOP lowering. Success of this surgery is limited by scarring of the ostomy, so this procedure is often accompanied by the use of antimetabolites, such as mitomycin C (MMC), to block the wound healing response. Although effective in preventing scarring, antimetabolites also yield unwanted side effects, such as hypotony and tissue degeneration due to cellular destruction. This study presents an alternative to antimetabolites by using gene therapy to introduce the human gene for p21WAF-1/cip-1 (p21) to cause cell cycle arrest of surrounding cells rather than their destruction. In this procedure, p21 was delivered using a recombinant adenovirus to ocular hypertensive monkey eyes. These eyes then underwent filtration surgery. Results show that eyes treated with p21 exhibited open surgical ostomies by both functional and histological criteria, and did not display any side effects seen in control animals that were treated with MMC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Quigley HA . Open-angle glaucoma. N Engl J Med 1993; 328: 1097–1106.
Quigley HA . The number of persons with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389–393.
Quigley HA et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994; 112: 644–649.
AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429–440.
Jay JL, Allan D . The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease. Eye 1989; 3: 528–535.
Hitchings RA et al. The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry. Eye 1994; 8: 117–120.
Lichter PR et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001; 108: 1943–1953.
Jampel HD et al. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmology 1988; 106: 89–94.
Skuta GL et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high risk glaucoma filtering surgery. Ophthalmology 1992; 99: 438–444.
Higginbotham EJ et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Opthalmology 1996; 103: 650–656.
Perkins TW et al. Trabeculectomy with mitomycin C: intermediate-term results. J Glaucoma 1998; 7: 230–236.
Bindlish R et al. Efficacy and safety of mitomycin-C in primary trabeculectomy: five year follow-up. Ophthalmology 2002; 109: 1336–1341.
Edmunds B, Thompson JR, Salmon JF, Wormald RP . The national survey of trabeculectomy, III. Early and late complications. Eye 2002; 16: 297–303.
Mietz H, Chevez-Barrios P, Feldman RM, Lieberman MW . Suramin inhibits wound healing following filtering procedures for glaucoma. Br J Ophthalmol 1998; 82: 816–820.
Cordeiro MF, Gay JA, Khaw PT . Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 1999; 40: 2225–2234.
Jampel HD, Moon JI . The effect of paclitaxel powder on glaucoma filtration surgery in rabbits. J Glaucoma 1998; 7: 170–177.
Wong TTL, Mead AL, Khaw PT . Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2003; 44: 1097–1103.
Perkins TW et al. Adenovirus-mediated gene therapy using human p21WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol 2002; 120: 941–949.
Harper JW et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805–816.
Gartel AL, Serfas MS, Tyner AL . p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996; 213: 138–149.
Crowston JG et al. Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci 1998; 39: 449–454.
Kitazawa Y, Kawase K, Matsushita H, Minobe M . Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol 1991; 109: 1693–1698.
Mermoud A, Salmon JF, Murray AD . Trabeculectomy with mitomycin C for refractory glaucoma in blacks. Am J Ophthalmol 1993; 116: 72–78.
Erhardt JA, Pittman RN . p21WAF1 induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells. Oncogene 1998; 29: 443–451.
Mobley SR, Liu TJ, Hudson JM, Clayman GL . In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy. Arch Otolaryngol Head Neck Surg 1998; 124: 88–92.
Quigley HA et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36: 774–786.
Kaufman PL, Wallow IH . Minifield diagnostic contact lenses for biomicroscopic examination and photocoagulation of the anterior and posterior segment in small primates. Exp Eye Res 1985; 40: 883–885.
Wills KN et al. Development and characterization of recombinant Adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther 1994; 5: 1079–1088.
Kaufman PL, Davis GE . Minifield Goldman applanating prism for tonometry in monkeys and humans. Arch Ophthalmol 1980; 98: 542–546.
Peterson JA, Kiland JA, Croft MA, Kaufman PL . Intraocular pressure measurement in cynomologus monkeys: tono-pen versus manometry. Invest Ophthalmol Vis Sci 1996; 37: 1197–1199.
Acknowledgements
This work was supported by funding from Canji, Inc. (La Jolla, CA, USA) to RWN and by a grant from the National Eye Institute (EY02698) to PLK. We thank Ms Gretchen Poulsen for her administration of the monkey colony and Ms Janice Lokken for processing and sectioning the surgery tissues.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heatley, G., Kiland, J., Faha, B. et al. Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. Gene Ther 11, 949–955 (2004). https://doi.org/10.1038/sj.gt.3302253
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302253
Keywords
This article is cited by
-
Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E
BMC Ophthalmology (2014)
-
Serial multifocal electroretinograms during long-term elevation and reduction of intraocular pressure in non-human primates
Documenta Ophthalmologica (2010)